Cargando…
SORLA regulates endosomal trafficking and oncogenic fitness of HER2
The human epidermal growth factor receptor 2 (HER2) is an oncogene targeted by several kinase inhibitors and therapeutic antibodies. While the endosomal trafficking of many other receptor tyrosine kinases is known to regulate their oncogenic signalling, the prevailing view on HER2 is that this recep...
Autores principales: | Pietilä, Mika, Sahgal, Pranshu, Peuhu, Emilia, Jäntti, Niklas Z., Paatero, Ilkka, Närvä, Elisa, Al-Akhrass, Hussein, Lilja, Johanna, Georgiadou, Maria, Andersen, Olav M., Padzik, Artur, Sihto, Harri, Joensuu, Heikki, Blomqvist, Matias, Saarinen, Irena, Boström, Peter J., Taimen, Pekka, Ivaska, Johanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538630/ https://www.ncbi.nlm.nih.gov/pubmed/31138794 http://dx.doi.org/10.1038/s41467-019-10275-0 |
Ejemplares similares
-
A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance
por: Al-Akhrass, Hussein, et al.
Publicado: (2021) -
L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling
por: Jacquemet, Guillaume, et al.
Publicado: (2016) -
Sortilin‐related receptor is a druggable therapeutic target in breast cancer
por: Al‐Akhrass, Hussein, et al.
Publicado: (2021) -
MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels
por: Närvä, Elisa, et al.
Publicado: (2022) -
FiloQuant reveals increased filopodia density during breast cancer progression
por: Jacquemet, Guillaume, et al.
Publicado: (2017)